DM	diabetes mellitus
CVD	cardiovascular disease
IL	interleukin
NLR	NOD-like receptor
ADC	Apoptosis-associated speck-like protein containing a CARD
NLRPs	NLR proteins
HIN	interferon-inducible nature, and nuclear localization
AIM2	absent in melanoma 2
IFI16	interferon γ-inducible protein 16
NLRP3	NACHT, LRR and PYD domains-containing protein 3
TLRs	toll-like receptors
PRRs	pattern recognition receptors
PAMPS	pathogen- associated molecular patterns
DAMPs	damage-associated molecular patterns
NF-κB	nuclear factor-κB
ATP	adenosine triphosphate
ROS	reactive oxygen species
AGEs	advanced glycation end-products
FFAs	free fatty acids
MACEs	major adverse cardiovascular events
CANTOS	Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
GLP	Glucagon-like peptide
SGLT	sodium glucose cotransporter
hsCRP	high-sensitivity C-reactive protein
CIRT	Cardiovascular Inflammation Reduction Trial
OxLDLs	oxidized LDLs
RAGE	receptor of AGEs
SREBP	sterol regulatory element binding protein
NETs	neutrophil extracellular traps
Foxp1	forkhead box P transcription factor 1
DKD	diabetic kidney disease
ESKD	end-stage kidney disease
GFR	glomerular filtration rate
RAS	renin-angiotensin system
KRIS	kidney risk inflammatory signature
TNF	tumor necrosis factor
BM	bone marrow
TXNIP	Thioredoxin Interacting Protein
PR2X7	purinergic receptor 2X7
DPP	dipeptidyl peptidase
DR	diabetic retinopathy
PDR	proliferative DR
STZ	streptozotocin
TRX1	thioredoxin
ALEs	advanced lipoxidation endproducts
PGE2	Prostaglandin E2
EP2R	E-prostanoid receptor
PPARα	peroxisome proliferator-activated receptor-α
NAFLD	nonalcoholic fatty liver disease
NASH	nonalcoholic steatohepatitis